Holen Sie sich die Stockscreener-App
12.28
2.16%
0.26
Schlusskurs vom Vortag:
$12.02
Offen:
$11.78
24-Stunden-Volumen:
368
Relative Volume:
0.02
Marktkapitalisierung:
$7.72M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.05M
KGV:
-5.7116
EPS:
-2.15
Netto-Cashflow:
$-17.78M
1W Leistung:
+13.86%
1M Leistung:
+32.04%
6M Leistung:
-55.36%
1J Leistung:
-87.73%
1-Tages-Spanne:
$11.78
$11.78
1-Wochen-Bereich:
$10.21
$12.85
52-Wochen-Spanne:
$8.67
$196.70
Envveno Medical Corporation Stock (NVNO) Company Profile
Firmenname
Envveno Medical Corporation
Sektor
Branche
Telefon
949-261-2900
Adresse
70 DOPPLER, IRVINE
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
11.78 | 7.76M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
110.14 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
356.22 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.94 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.86 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.38 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Envveno Medical Corporation Aktie (NVNO) Neueste Nachrichten
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Independent Mail
NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - The Manila Times
Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO) - Defense World
NVNO SEC FilingsEnvveno Medical Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
NVNO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can enVVeno Medical Corporation maintain sales growthQuarterly Profit Summary & Daily Growth Stock Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
enVVeno Medical (NVNO) investor urges halt to trials, strategic review - Stock Titan
enVVeno Medical Announces Reverse Stock Split - Press & Sun-Bulletin
Perceptive funds hold 2.05M enVVeno (NVNO) shares and warrants - Stock Titan
NVNO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Strategic Investor Acquires Significant Stake in enVVeno Medical - AD HOC NEWS
Investor Braeden Lichti discloses 5.05% enVVeno (NVNO) ownership stake - Stock Titan
Aug Analyst Calls: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn
Head to Head Analysis: LENSAR (NASDAQ:LNSR) versus enVVeno Medical (NASDAQ:NVNO) - Defense World
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - The Northwest Florida Daily News
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - DelmarvaNow.com
enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans - The Globe and Mail
EnVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - News Channel Nebraska Southeast
enVVeno Medical regains Nasdaq compliance, reports $28 million cash By Investing.com - Investing.com Nigeria
enVVeno Medical regains compliance with Nasdaq minimum bid price rule - TipRanks
enVVeno Medical Regains Nasdaq Compliance - Orange County Business Journal
enVVeno Medical regains Nasdaq compliance, reports $28 million cash - Investing.com
Bank Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Performance Recap & Smart Investment Allocation Tips - baoquankhu1.vn
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Green Bay Press-Gazette
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Breakout Zone: Why is Pliant Therapeutics Inc stock going upJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Volume Report: Will enVVeno Medical Corporation benefit from seasonalityShort Setup & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Finanzdaten der Envveno Medical Corporation-Aktie (NVNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):